Literature DB >> 1417088

Influence on erythropoietin levels of treatment with cisplatinum-endoxan.

W Lechner1, E Artner-Dworzak, E Sölder, M Sachsenmaier, D Kölle, H Moncayo, R Reitsamer.   

Abstract

Erythropoietin levels have been determined in 24 patients with different gynecologic malignancies, who were treated with cisplatinum and endoxan. A statistically highly significant decrease was demonstrated 2 h after starting treatment with a further significant decrease at 6 h. After 12 h the erythropoietin concentrations returned to values similar to those before treatment started.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1417088     DOI： 10.1007/bf02389607

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


  11 in total

1.  Role of the kidney in erythropoiesis.

Authors:  L O JACOBSON; E GOLDWASSER; W FRIED; L PLZAK
Journal:  Nature       Date:  1957-03-23       Impact factor: 49.962

2.  Humoral regulation of red cell production.

Authors:  A ERSLEV
Journal:  Blood       Date:  1953-04       Impact factor: 22.113

3.  Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia.

Authors:  K R REISSMANN
Journal:  Blood       Date:  1950-04       Impact factor: 22.113

4.  Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons.

Authors:  A Al-Khatti; R W Veith; T Papayannopoulou; E F Fritsch; E Goldwasser; G Stamatoyannopoulos
Journal:  N Engl J Med       Date:  1987-08-13       Impact factor: 91.245

5.  Purification of human erythropoietin.

Authors:  T Miyake; C K Kung; E Goldwasser
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

6.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

Authors:  J W Eschbach; J C Egrie; M R Downing; J K Browne; J W Adamson
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

7.  Erythropoietin treatment of anemia associated with multiple myeloma.

Authors:  H Ludwig; E Fritz; H Kotzmann; P Höcker; H Gisslinger; U Barnas
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

8.  Supraventricular tachycardia. A probable complication of platinum treatment.

Authors:  L A Hashimi; M F Khalyl; P A Salem
Journal:  Oncology       Date:  1984       Impact factor: 2.935

9.  Isolation and characterization of genomic and cDNA clones of human erythropoietin.

Authors:  K Jacobs; C Shoemaker; R Rudersdorf; S D Neill; R J Kaufman; A Mufson; J Seehra; S S Jones; R Hewick; E F Fritsch
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

10.  Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

Authors:  C G Winearls; D O Oliver; M J Pippard; C Reid; M R Downing; P M Cotes
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.